Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma
BMC Cancer Sep 13, 2017
Yang L, et al. - Study's objective was to establish nomograms to effectively predict skeletal metastasis at initial diagnosis (SMAD) and skeletal metastasis-free survival (SMFS) in nasopharyngeal carcinoma (NPC). The prognostic nomograms were established and enabled accurate stratification of distinct risk groups for skeletal metastasis. It seemed to improve counseling and facilitate individualized management of patients with NPC.
Methods
- In order to develop individual nomograms for SMAD and SMFS, 2685 patients with NPC who received bone scintigraphy (BS) and/or 18FÂdeoxyglucose positron emission tomography/computed tomography (18FÂFDG PET/CT) and 2496 patients without skeletal metastasis were retrospectively assessed.
- By using separate cohorts of 1329 and 1231 patients treated at two other institutions, the models were validated externally.
Results
- Each nomogram incorporated five independent prognostic factors.
- Results revealed a significantly higher c-index in SMAD nomogram than the TNM staging system (training cohort, P = 0.005; validation cohort, P < 0.001).
- In comparison to the TNM staging system, the SMFS nomogram had significantly higher c-index values in the training and validation sets (P < 0.001 and P = 0.005, respectively).
- By using the nomograms, three proposed risk stratification groups were created, and enabled significant discrimination of SMFS for each risk group.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries